Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 193,451 | 394,590 | 527,266 | 147,154 |
| Marketable Securities | N/A | N/A | N/A | 4,848 | 94,987 |
| Receivables | N/A | 13,552 | 21,648 | 31,183 | 40,120 |
| Inventories | N/A | 39,773 | 18,942 | 9,147 | 2,884 |
| Other current assets | 0 | 52,583 | 63,042 | 53,613 | 111,182 |
| TOTAL | $N/A | $313,895 | $517,217 | $640,443 | $398,031 |
| Non-Current Assets | |||||
| PPE Net | N/A | 5,520 | 7,387 | 7,222 | 38 |
| Investments And Advances | 0 | 82,267 | 0 | 0 | 0 |
| Intangibles | 0 | 289,494 | 427,829 | 565,046 | 630,860 |
| Other Non-Current Assets | 0 | 24,943 | 11,303 | 30,412 | 186,458 |
| TOTAL | $N/A | $402,224 | $446,519 | $602,680 | $817,356 |
| Total Assets | $N/A | $716,119 | $963,736 | $1,243,123 | $1,215,387 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 17,370 | 13,142 | 19,785 | 7,016 |
| Other current liabilities | N/A | N/A | N/A | N/A | 88,001 |
| TOTAL | $N/A | $45,693 | $52,470 | $193,109 | $130,315 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 77,428 | 181,487 | 204,171 | 329,596 |
| TOTAL | $N/A | $77,148 | $181,487 | $204,124 | $329,649 |
| Total Liabilities | $N/A | $122,841 | $233,957 | $397,233 | $459,964 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,516 | 123,592 | 128,109 | 153,812 | 165,558 |
| Common Shares | N/A | 1,243 | 1,365 | 1,538 | 1,655 |
| Retained earnings | N/A | 670,832 | 828,547 | 945,614 | 857,116 |
| Other shareholders' equity | 0 | 78 | -103 | 1,181 | 4,280 |
| TOTAL | $N/A | $593,278 | $729,779 | $845,890 | $755,423 |
| Total Liabilities And Equity | $0 | $716,119 | $963,736 | $1,243,123 | $1,215,387 |